In recent years, maternal and infant deaths, doctor-patient disputes and other incidents caused by pregnancy preeclampsia have also been reported frequently. Preeclampsia is a serious complication during pregnancy that seriously threatens maternal safety and infant health. Therefore, how to increase women\’s fertility rate and achieve prenatal and postnatal care while ensuring the safety of mothers and infants has become a hot topic of concern to all sectors of society.
Preeclampsia is one of the leading causes of maternal and fetal death and complications during pregnancy, with a worldwide incidence of approximately 3%-5% of all pregnancies. As preeclampsia continues to worsen, eclampsia can be induced and convulsions can occur. Approximately 15% of preterm births and 42% of maternal deaths worldwide are caused by preeclampsia.
The cause of preeclampsia is not completely clear at present, but may be related to factors such as excessive activation of inflammatory immunity, damage to vascular endothelial cells, genetic factors, nutritional deficiencies, insulin resistance, etc. It can also cause spasm of small blood vessels throughout the body, endothelial damage, and local ischemia. It leads to reduced blood perfusion in various systems and organs throughout the body, causing harm to the mother and fetus.
Professor Cheng Weiwei from the International Peace Maternal and Child Health Hospital pointed out: \”Preeclampsia develops rapidly, and even pregnant women in a healthy pregnancy will develop symptoms. The only treatment is to terminate the pregnancy in time. Therefore, it is very important to identify the risk of preeclampsia early. Through Close monitoring and prevention of patients to minimize the development of serious disease and safely prolong pregnancy can effectively reduce hospitalization and mortality rates among pregnant women.\”
Studies have found that the blood of pregnant women contains anti-angiogenic factors and pro-angiogenic factors, and their ratio can better reflect the growth of placental blood vessels, which is closely related to the occurrence of preeclampsia. Currently, the Roche Diagnostics Elecsys Preeclampsia Test measures the ratio of these two factors and provides results in just 18 minutes. It can more accurately identify pregnant women who may be at high risk of preeclampsia than traditional methods.
Professor Cheng Weiwei said: \”On the basis of evaluating proteinuria and blood pressure, jointly detecting the ratio of these two factors can help us better predict the risk of disease, detect and intervene in high-risk groups early, and ensure safety. It is recommended for first-time pregnancies and pregnancies. Preeclampsia in the second pregnancy, family history of preeclampsia, young pregnant women or over 40 years old, multiple pregnancy, kidney disease or high blood pressure, obese pregnant women, 20 weeks postpartum, weekly A preeclampsia test.”